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Summary Data from the Registry of Digestive tumours of the D6partement of Cote d'Or (France) were used to study the characteristics of
gastrointestinal non-Hodgkin's lymphomas in the 1976-90 period. The mean annual age-standardized incidence rate was 0.94 per 100 000
for men, and 0.54 per 100 000 for women. Incidence varied little during the study period. Overall 5-year survival rate was 34.3 ± 5.6%.
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Only two population-based series of gastrointestinal non-
Hodgkin's lymphomas (NHL) have been described (Otter et al,
1989a; D'Amore et al, 1994). The data from the Registry of
Digestive Tract Tumours of the Departement of C6te d'Or
(France) created in 1976 enabled us to study the epidemiological
characteristics ofdigestive NHL.
MATERIALS AND METHODS
Patients
A population-based cancer registry, limited to digestive tumours,
exists on the resident population of the COte d'Or, Burgundy,
France (473 651 inhabitants at the time of the 1982 census). This
study covers the 78 cases of primary gastrointestinal NHL diag-
nosed during the first 15 years of the Registry, i.e. between
January 1976 and December 1990.
In the Registry, information is routinely collected from
pathology laboratories, university hospitals, local hospitals,
surgeons, gastroenterologists, general practitioners, Social
Security offices, and monthly reviews of death certificates. For
this study, a special inquiry addressed to all gastroenterologists
and oncologists was conducted to ensure complete collection of
the cases. All pathological samples of digestive cancers that had
been classified as anaplastic were reviewed with immunohisto-
chemical staining. This procedure permitted retrospective diag-
nosis ofsix gastric NHLs.
Primary gastrointestinal NHL was defined according to Lewin
et al (1978): it occurs in a patient presenting with digestive symp-
toms and in whom NHL is confined to, or is clearly predominant
within, the digestive tract. Patients with a digestive site discovered
during staging investigations of a NHL were excluded from the
study. The mesenteric localizations were considered to be primary
intestinal NHL in accordance with the literature (Otter et al, 1989a
Weingrad et al, 1982; Dragosics et al, 1985).
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A population-based registry limited to haematopoietic malig-
nancies was created in January 1980 (Carli et al, 1986). It covers
the same resident population as the Registry ofDigestive Tumours
and was used to place gastrointestinal cases of NHL in context
among other cases ofNHL, in particular ofnodal NHL.
Study variables
Date and place ofbirth, sex, place ofresidence, clinical features at
presentation, histology and stage ofthe disease were collected for
each patient. Place ofresidence was recorded as rural or urban, an
urban area being defined as comprising over 2000 inhabitants.
Grade was established for all patients according to the Kiel and the
Isaacson classifications as low or high (Stansfeld et al, 1988;
Rohatiner et al, 1994). In addition, information on the exactpatho-
logical type according to the Kiel classification was obtained for
61 patients (78.2%). Stage was assigned using the Ann Arbor
system modified for extranodal lymphomas, which recognizes
four stages (Carbone et al, 1971). When detailed information on
local lymph node involvement was not available, we considered
two groups: localized NHL (stage I or II) and disseminated NHL
(stage III or IV).
Survival data were obtained from the patients' medical files and
death certificates. One case ofgastric lymphoma was diagnosed at
autopsy and therefore was excluded from survival analyses.
Seventy-six patients (98.7%) were known to be alive at the time of
analysis, September 1995. Two patients who had received only
symptomatic treatment were excluded from this analysis.
Statistical analysis
Incidence rates were calculated on an annual basis. Population
data used in calculating incidence rates were based on annual esti-
mates of the Cote d'Or population by interpolation between the
1975, 1982 and 1990 censuses. For the purpose of geographical
comparisons, rates were standardized by the direct method using
the World Standard Population (Segi and Kurihara, 1969). To
describe the trend in digestive NHL incidence, an exponential
curve of the form y = a exp b' was fitted to the annual incidence
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rates by means ofaregression technique. This method allowed for
a direct interpretation of the average annual per cent change.
Relative survival was used to estimate net survival, which
excludes deaths not related to the disease itself. Rates were calcu-
lated with the Esteve method (Esteve et al, 1990), using the age
and sex specific French mortality tables.
RESULTS
Incidence by sex, age and place of residence
A total of78 cases ofgastrointestinal NHL were diagnosed during
the 15 years of the study in 43 men and 35 women. Incidence and
survival rates are presented in Table 1. The overall age-standard-
ized incidence rates were 0.94 per 100 000 and 0.54 per 100 000
with a male-female ratio of 1.74. Ages ranged between 7 and 87
years (mean = 63.2 ± 2.1 years). Age-specific incidence curves by
sex are displayed in Figure 1. Eleven cases (14.1%) were diag-
nosed inpatients under age 45 years. Incidence was similarin rural
and in urban areas (0.81 per 100 000 vs 0.74 per 100 000; NS).
During the study period, incidence increased slightly by an
average of 1.7% per year (95% Cl; - 3.2; + 6.6; NS).
Frequency of gastrointestinal NHL among all types of
NHL and among digestive cancers
Between January 1980 and December 1990, 401 cases of NHL
were diagnosed among COte d'Or residents. Gastrointestinal NHL
represented 15.7% ofall NHL cases and 59% ofextranodal cases.
In the 15 years of the study, 4681 cases of gastrointestinal
cancer were diagnosed among Cote d'Or residents. Gastro-
intestinal NHL cases thus represented 1.7% of all digestive tract
cancers. In patients under age 45 years, NHL represented a higher
proportion of digestive tract neoplasms than in patients over this
age: 6.5% vs 1.5% (P < 0.001).
Location of gastrointestinal NHL
The stomach was the most common site ofthe disease (42 patients,
53.8%), compared with 13 cases (16.7%) of small bowel NHL, 12
patients (15.4%) with colon NHL, nine (11.5%) patients with
rectum NHL and two (2.6%) with mesenteric NHL. NHL cases
thus represented 3.7% of all gastric malignant neoplasms, 18.8%
of small bowel malignant neoplasms, 0.6% of colon malignant
neoplasms, 0.7% ofrectal malignant neoplasms and 9.5% ofperi-
toneal or mesenteric malignant neoplasms. Age distribution varied
according to location within the digestive tract. Cases arising
before age 45 years represented 7.1% of gastric NHL, 46.2% of
small bowel, 16.7% ofcolon, and 0% ofrectal or mesenteric NHL
(P < 0.01).
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Figure 1 Age-specific incidence patterns for digestive non-Hodgkin's
lymphomas. -, Men; ..., women
Symptoms
Abdominal pain was the most common complaint ofpatients with
gastrointestinal NHL (n = 33, 42.3%). Other features at presenta-
tion were acute digestive obstruction (12.8%), body-weight loss
(12.8%), patent digestive tract-intestinal bleeding (11.5%),
abdominal mass (7.7%) and anaemia (6.4%). Diagnosis was estab-
lished at autopsy in one case of gastric lymphoma. In this series,
no case ofHIV infection was recorded.
Stage
The disease was diagnosed at stage I in 19.2% of the patients, at
stage II in 42.3%, at stage III in 2.6%, at stage IV in 16.7%. Stage
could notbe determined in 19.2% (15 cases); however, in 12 outof
these 15 patients, it was possible to classify the disease as local-
ized. Therefore, 60 patients had a localized NHL, 15 a dissemi-
nated NHL and three a completely unknown stage of the disease.
Stage ofthe disease was not influenced by NHL location.
Histological classification
According to the Kiel classification, 51.3% ofthe cases were low-
grade NHL and 48.7% high-grade NHL. Grade varied little with
location. High-grade NHL was slightly more common after
December 1984 (n = 21) than before (n = 17), 53.8% and 43.6%
respectively, NS. According to the Isaacson's classification, there
were 26 low-grade B-cell lymphomas of mucosa associated
lymphoid tissue (MALT), 44 high-grade B-cell lymphomas of
MALT, one immunoproliferative small intestinal disease, one
mantle cell lymphoma, two Burkitt- like lymphomas and two other
Table 1 Age-standardized incidence and survival rates for gastrointestinal non-Hodgkin's lymphoma in C6te d'Or, Burgundy
Total All sites Stomach Small bowel Colon Rectum
(n =78) (n =42) (n = 13) (n = 12) (n =9)
(per 100000) (per 100 000) (per 100 000) (per 100000) (per 100 000)
Men 43 0.94 0.74 0.20 0.17 0.11
Women 35 0.54 0.44 0.16 0.16 0.14
Five-year survival - 34.3 ± 7.0 40.5 ± 7.8 22.2 ± 12.8 16.7 ± 10.8 44.4 ± 16.6
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types of low- or high-grade NHL corresponding to peripheral
lymph node equivalents.
Survival
The 1-year crude survival rate was 55.6 ± 5.7% (± s.d.); 2-year and
5-year crude survival rates were, respectively, 48.7 ± 5.7% and
34.3 ± 5.6%. Corresponding figures forrelative survival rates were
56.3 ± 6.0%, 50.9 ± 5.7% and 37.5 ± 7.0%.
Five-year survival was slightly higher for gastric and rectal
NHL. One of the patients with a mesenteric NHL died after 11
months and the other was still alive 57 months after diagnosis.
DISCUSSION
The epidemiological characteristics of gastrointestinal NHL that
appear in this study are somewhat different from those previously
reported. Incidence in our series was 1.5-2 times higher than has
been estimated in the US by Heath et al (1982) from hospital
series. However, this difference may be due to special care in
uncovering cases, in the present study, with histological review of
cases of undeterminate diagnosis. Hospital series may also under-
register very old patients. Our incidence rates are also slightly
higher than those reported by the Danish Lymphoma Study Group
from Denmark (0.71 per 100 000 and + 0.48 per 100 000 for men
and women respectively) (D'Amore et al, 1994).
Gastrointestinal NHL cases represented more than 50% of
extranodal NHL cases when we cross-checked the two registries
that cover the Cote d'Or area. Ourproportion was greater than was
reported earlier from the Connecticut Tumor Registry, 44%
(Zheng et al, 1992); or from the Danish population study
(1983-88), 30% (D'Amore et al, 1991); or the Dutch population
study, 36% (Otter et al, 1989b). If we consider digestive NHL
among all NHL types, this proportion (17%) is also higherthan the
proportion from the Connecticut Tumor Registry (about 9%)
(Zheng et al, 1992). Again, the relatively high proportion in the
present study may be partly due to a more active search for
gastrointestinal NHLs.
No obvious time trend in the incidence ofgastrointestinal NHL
could be demonstrated in the C8te d'Or over the past 15 years,
whereas a sharp trend, for all NHL types (Carli et al, 1986) and in
particular for gastric NHL, had been indicated in reports of the
Surveillance, Epidemiology and End Results (SEER) programme
ofthe National Cancer Institute (Severson and Davis, 1990; Zheng
et al, 1992). The retrospective discovery ofsix cases over the first
7 years of our series leads us to suspect better recognition of this
disease as the main reason forthe reported trends. No time trend in
incidence was observed in the only other study that has reported
incidence rates of gastrointestinal NHL in a defined population
(D'Amore et al, 1994).
The observed male predominance is a well-known (unexplained)
feature of gastrointestinal NHL, also found in other types (Cantor
and Fraumeni, 1980), with a sex ratio as high as 2.5 in some series
(Elias, 1979). An excess of urban cases is usually reported in the
literature (Devesa and Fears, 1992). Such a difference was not
observed in our series, possibly because of an increasingly large
proportion ofthe rural population working in towns and thus poten-
tially exposed to urban environmental factors. This is consistent
with the observation that in the USA the urban-rural ratio is
decreasing over time (Devesa and Fears, 1992).
The combination of a digestive tract cancer registry and a
registry ofhaematopoietic malignancies enabled us to estimate the
importance ofgastrointestinal NHL among other types of NHL as
well as among other digestive malignancies. Although the stomach
is the most common location ofgastrointestinal NHL, with propor-
tions as high as 80% in some hospital series (Lewin et al, 1978;
Rambaud, 1983; Williamson et al, 1983; Aozasa et al, 1988; List et
al, 1988; Gobbi et al, 1990), NHL represents only 4% ofall gastric
malignancies, whereas it accounts for almost 20% of small bowel
neoplasms. These data are only typical ofthose from western non-
Latin European countries or from North America. The situation is
likely to be quite different in Mediterranean countries with the
problem ofthe alpha-chain disease that occurs in the small bowel
(Galian etal, 1977). This disease is very rare inBurgundy, aregion
of France that is at some distance from the Mediterranean, (only
one case was observed in our series, in a North African patient).
High- and low-grade NHL types were equally distributed in our
series, which is in agreement with other studies (Dworkin et al,
1982; Gobbi et al, 1990). As for subtypes, the distribution of low-
grade NHL was similar to that of other series, the most common
types being the lymphoplasmocytoid and the diffuse centro-
blastic-centrocytic forms (Lennert et al, 1975; Aozasa etal, 1988).
For high-grade NHL, the centroblastic type was twice as common
as the immunoblastic type, whereas they are usually equally repre-
sented in extranodal or digestive NHL series (Dragosics et al,
1985; Carli et al, 1986). According to the Isaacson classification,
high-grade NHL seems twice as frequent as low-grade NHL, a
feature that has already been observed in recent hospital series
(Ruskone-Fourmestreaux et al, 1993).
Hospital series usually provide rather high survival figures for
gastrointestinal NHL (Weingrad et al, 1982). This population-
based series demonstrates that gastrointestinal NHL is a severe
disease with an overall 5-year survival rate of only 34.3%.
Relative survival reported here for the first time is not very
different from crude survival. Betterrecognition ofthe disease and
changes in chemotherapy protocols have not improved prognosis,
which has not changed with time. However, for gastric NHL
overall 5-year survival was 40.5%, whereas in the same population
series it was only 12% for gastric carcinomas (Hillon et al, 1983).
Gastrointestinal NHLhas raised great interest amongphysicians
over the recent decades. The present study gives an unbiased
picture ofits occurrence in a defined population.
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